期刊文献+

儿童肺动脉高压诊疗现状与展望 被引量:13

下载PDF
导出
摘要 肺动脉高压(PAH)是以肺血管阻力进行性升高和右心功能衰竭为主要特点,导致儿童发病和致死的严重疾病。儿童具有特殊的肺血管的生理和病理改变,其发病机制、临床分类及治疗方法都与成人有所不同。随着成人PAH的靶向药物治疗的进展,多种不同类型PAH患者的生存率得到了明显改善,
作者 顾虹
出处 《心肺血管病杂志》 CAS 2012年第4期355-357,共3页 Journal of Cardiovascular and Pulmonary Diseases
  • 相关文献

参考文献24

  • 1Rashid A,Dunbar D.Pulmonary Hypertension in Children//Pulmonary vascular disease.Elsevier,Philadelphia:Sarnders,2006:274-287. 被引量:1
  • 2Hoehn T.Therapy of pulmonary hypertension in neonates and in-fants.Pharmacol Ther,2007,114:318-326. 被引量:1
  • 3Yung D,Widlitz AC,Rosenzweig EB,et al.Outcomes in chil-dren with idiopathic pulmonary arterial hypertension.Circula-tion,2004,110:660-665. 被引量:1
  • 4Solari V,Piotrowska AP,Puri P.Expression of heme oxygenase-1 and endothelial niric oxide synthase in the lung of newbornswith congenital diaphragmatic hernia and persistent pulmonaryhypertension.J Pediatric,2003,38:803-813. 被引量:1
  • 5佐地,ほか.小児期原発性肺高血圧の全国調査.日本小児循環器学会誌,2000,16:230-237. 被引量:1
  • 6Simonnea G,Robbins IM,Beghetti M,et al.Updated clinicalclassification of pulmonary hypertension.J Am Coll Cardiol,2009,54:43-54. 被引量:1
  • 7Humbert M,McLaughlin VV.The 4th world symposium on pul-monary hypertension.J Am Coll Cardiol,2009,54:1-2. 被引量:1
  • 8Van Loon RL,Roofthooft MT,Van Osch-Gevers M,et al.Clini-cal characterization of pediatvic pulmonary hypertenson complexpresentation and diagnosis.J Pediatr,2001,155:176-182. 被引量:1
  • 9Berger RM,Beghetti M,Humpl T,et al.Clinical features of pe-diatric pulmonary hypertension:a registry study.Lancet,2012,379:537-546. 被引量:1
  • 10Fasnacht MS,Tolsa JF,Beghetti M.The Swiss registry for pul-monary arterial hypertension:the paediatric experience.SwissMed Wkly,2007,137:510-513. 被引量:1

二级参考文献36

  • 1Singh TP,Rohit M,Grover A,菅鑫妍.口服西地那非疗法治疗严重肺动脉高压的效果研究[J].中国处方药,2006(8):29-29. 被引量:49
  • 2周其文 薛淦兴 等.先心病合并重度肺动脉高压的手术指征-143例临床分析[J].中国循环杂志,1987,2:390-392. 被引量:1
  • 3Dimopoulos K,Giannakoulas G,Wort SJ,et al.Pulmonary arterial hypertension in adults with congenital heart disease:distinct differences from other causes of pulmonary arterial hypertension and management implications.Curr Opin Cardiol,2008,23:545-554. 被引量:1
  • 4Gorenflo M,Bettendorf M,Brockmeier K,Pulmonary vasoreactivity and vasoactive mediators in children with pulmonary hypertension.Z Kardiol,2000,89:1000-1008. 被引量:1
  • 5Wilkinson JL.Haemodynamic calculations in the catheter laboratory.Heart,2001,85:113-120. 被引量:1
  • 6Viswanathan S,Kumar RK.Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance.Catheter Cardiovasc Interv,2008,71:665-670. 被引量:1
  • 7Galie N,Manes A,Palazzini M,et al.Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger' s syndrome.Drugs,2008,68:1049-1066. 被引量:1
  • 8Olschewski H,Simonneau G,Galie N,et al.Inhaled iloprost for severe pulmonary hypertension.N Engl J Med,2002,347:322-329. 被引量:1
  • 9Strauss WL,Edelman JD.Prostanoid therapy for pulmonary arterial hypertensioa Clin Chest Med,2007,28:127-142. 被引量:1
  • 10Siobal MS.Pulmonary vasodilators.Respir Care,2007,52:885-899. 被引量:1

共引文献28

同被引文献107

引证文献13

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部